| Direct Competitor Comparison | |
|---|
| CVD | CRL | PVT1 | PVT2 | Industry |
|---|
| Market Cap: | 4.27B | 2.20B | N/A | N/A | 29.59B |
|---|
| Employees: | 11,160 | 7,200 | N/A | 27,4121 | 38.90k |
|---|
| Qtrly Rev Growth (yoy): | 0.09 | 0.02 | N/A | N/A | 1.57 |
|---|
| Revenue (ttm):
| 2.23B | 1.13B | N/A | 4.87B1 | 12.64B |
|---|
| Gross Margin (ttm): | 0.29 | 0.35 | N/A | N/A | 0.43 |
|---|
| EBITDA (ttm): | 314.13M | 255.35M | N/A | N/A | 2.65B |
|---|
| Operating Margin (ttm):
| 0.09 | 0.15 | N/A | N/A | 0.13 |
|---|
| Net Income (ttm): | 107.21M | 100.92M | N/A | 176.60M1 | N/A |
|---|
| EPS (ttm): | 1.93 | 2.00 | N/A | N/A | 3.39 |
|---|
| P/E (ttm): | 39.53 | 22.49 | N/A | N/A | 24.34 |
|---|
| PEG (5 yr expected): | 1.72 | 2.05 | N/A | N/A | 1.45 |
|---|
| P/S (ttm): | 1.94 | 1.94 | N/A | N/A | 2.34 |
|---|
|
| CRL = Charles River Laboratories International, Inc. | | Pvt1 = Pharmaceutical Product Development, LLC (privately held) | | Pvt2 = Quintiles Transnational Holdings, Inc. (privately held) | | Industry = Medical Laboratories & Research | | 1 = As of 2012 |
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
0.88(1.14%) May 20, 4:03PM EDT